Bed scale could help wheelchair users shed pounds

NCT ID NCT07141342

Recruiting now Disease control Sponsor: Jonathan Pearlman Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 30, 2026 · Updated 4 times

Summary

This study tests a special bed scale that automatically weighs wheelchair users when they get in and out of bed. The goal is to help them lose weight by providing daily feedback, combined with a lifestyle program. About 92 adults who use wheelchairs and are overweight or obese will participate for 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Fast In-Bed Tracking (FIT) System bed scale and Group Lifestyle Balance Adapted for Individuals with Impaired Mobility (GLB-AIM) behavioral program
What this could lead to: If successful, this could provide a convenient way for wheelchair users to track their weight daily, helping them lose weight and reduce obesity-related health risks.
What could go wrong: This is a small, early-stage trial with 92 participants, so results may not apply to all wheelchair users. The device only works for those who transfer in and out of bed, and weight loss success depends on user adherence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DISABILITY PHYSICAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Obesity obesity disorder Overweight

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DISABILITY PHYSICAL OBESITY & OVERWEIGHT WHEELCHAIR

Contacts and locations

Locations

University of Pittsburgh, Bakery Square, Department of Rehabilitation Science and Technology
RECRUITING

Pittsburgh, Pennsylvania, 15206, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.